Pharmacokinetics of cefoxitin in patients undergoing hemodialysis. 1979

M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román

The parmacokinetics of Cefoxitin were studied after an i.v. administration of 15 mg/kg body weight in 17 patients with terminal renal impairment, 10 of which were undergoing 6 hr hemodialysis sessions. The average pharmokinetic parameters obtained from this kind of patient were the following: alpha = 2.88 hr-1 beta = 0.18 hr-1 K12 = 1.43 hr-1 K21 = 1.04 hr-1 K13 = 0.53 hr-1 Vc = 8.23 l Vp = 11.61 l Vdss = 19.84 l. The amounts of the antibiotic in the central and peripheric compartments are established together with the amount of the antibiotic eliminated as a function of time. The pharmacokinetic parameters are significantly different from those established in the period between dialysis sessions, and thus, the elimination constant reaches a value of 0.28 h-1. The degree of plasma protein binding of Cefoxitin is 41.46% during the hemodialysis sessions. A dosage regimen is programmed as a function of the pharmacokinetic parameters established for this kind of patient. It is recommended that an i.v. dose of 15 mg/kg body weight should be administered at the beginning and end of each dialysis session lasting 6 hours, when the periods between the sessions are 48 hours.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
May 2012, European journal of clinical pharmacology,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
January 1982, Methods and findings in experimental and clinical pharmacology,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
September 1979, International journal of clinical pharmacology and biopharmacy,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
December 1991, The Japanese journal of antibiotics,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
July 1991, Journal of clinical pharmacology,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
January 1983, Nephron,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
October 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
April 2017, Hemodialysis international. International Symposium on Home Hemodialysis,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
December 1991, Minerva medica,
M J Garcia, and A Dominguez-Gil, and J M Tabernero, and A Bondia Román
May 1988, American journal of surgery,
Copied contents to your clipboard!